Generation and characterization of transgenic mice hyper-expressing melanoma tumour antigen p97 (Melanotransferrin): No overt alteration in phenotype

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1793, Issue 7, 2009, Pages 1210-1217

  Rahmanto, Yohan Suryo ^a   Richardson, Des R ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Iron; Melanotransferrin; Transferrin

Indexed keywords

COPPER; CREATINE; IRON; MELANOTRANSFERRIN; MESSENGER RNA; TRANSFERRIN; UNCLASSIFIED DRUG; ZINC;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; CREATININE BLOOD LEVEL; ERYTHROCYTE COUNT; FEMALE; FERTILITY; GENE FUNCTION; GENE OVEREXPRESSION; HETEROZYGOSITY; HISTOLOGY; IRON BINDING CAPACITY; IRON BLOOD LEVEL; IRON METABOLISM; LENTIVIRINAE; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; ORGAN WEIGHT; PHENOTYPE; PRIORITY JOURNAL; PROGENY; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SEX DIFFERENCE; THROMBOCYTE COUNT; TRANSGENIC MOUSE;

ANIMALS; ANTIGENS, NEOPLASM; BODY WEIGHT; COPPER; ERYTHROCYTE COUNT; FEMALE; HUMANS; IRON; MALE; MICE; MICE, TRANSGENIC; NEOPLASM PROTEINS; ORGAN SIZE; PHENOTYPE; ZINC;

ANIMALIA; MUS; MUS MUSCULUS;

EID: 67649404667     PISSN: 01674889     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2009.02.003     Document Type: Article

References (51)

1. Parkin D.M., Bray F., Ferlay J., and Pisani P. Global cancer statistics, 2002. CA Cancer J. Clin. 55 (2005) 74-108
2. Brown J.P., Nishiyama K., Hellstrom I., and Hellstrom K.E. Structural characterization of human melanoma-associated antigen p97 with monoclonal antibodies. J. Immunol. 127 (1981) 539-546
3. Woodbury R.G., Brown J.P., Yeh M.Y., Hellstrom I., and Hellstrom K.E. Identification of a cell surface protein, p97, in human melanomas and certain other neoplasms. Proc. Natl. Acad. Sci. U. S. A. 77 (1980) 2183-2187
4. Natali P.G., Roberts J.T., Difilippo F., Bigotti A., Dent P.B., Ferrone S., and Liao S.K. Immunohistochemical detection of antigen in human primary and metastatic melanomas by the monoclonal antibody 140.240 and its possible prognostic significance. Cancer 59 (1987) 55-63
5. McNagny K.M., Rossi F., Smith G., and Graf T. The eosinophil-specific cell surface antigen, EOS47, is a chicken homologue of the oncofetal antigen melanotransferrin. Blood 87 (1996) 1343-1352
6. Danielsen E.M., and van Deurs B. A transferrin-like GPI-linked iron-binding protein in detergent-insoluble noncaveolar microdomains at the apical surface of fetal intestinal epithelial cells. J. Cell Biol. 131 (1995) 939-950
7. Sciot R., de Vos R., van Eyken P., van der Steen K., Moerman P., and Desmet V.J. In situ localization of melanotransferrin (melanoma-associated antigen P97) in human liver. A light- and electron microscopic immunohistochemical study. Liver 9 (1989) 110-119
8. Kawamoto T., Pan H., Yan W., Ishida H., Usui E., Oda R., Nakamasu K., Noshiro M., Kawashima-Ohya Y., Fujii M., Shintani H., Okada Y., and Kato Y. Expression of membrane-bound transferrin-like protein p97 on the cell surface of chondrocytes. Eur. J. Biochem. 256 (1998) 503-509
9. Yamada T., Tsujioka Y., Taguchi J., Takahashi M., Tsuboi Y., Moroo I., Yang J., and Jefferies W.A. Melanotransferrin is produced by senile plaque-associated reactive microglia in Alzheimer's disease. Brain Res. 845 (1999) 1-5
10. Brown J.P., Hewick R.M., Hellstrom I., Hellstrom K.E., Doolittle R.F., and Dreyer W.J. Human melanoma-associated antigen p97 is structurally and functionally related to transferrin. Nature 296 (1982) 171-173
11. Brown J.P., Woodbury R.G., Hart C.E., Hellstrom I., and Hellstrom K.E. Quantitative analysis of melanoma-associated antigen p97 in normal and neoplastic tissues. Proc. Natl. Acad. Sci. U. S. A. 78 (1981) 539-543
12. Rose T.M., Plowman G.D., Teplow D.B., Dreyer W.J., Hellstrom K.E., and Brown J.P. Primary structure of the human melanoma-associated antigen p97 (melanotransferrin) deduced from the mRNA sequence. Proc. Natl. Acad. Sci. U. S. A. 83 (1986) 1261-1265
13. Sekyere E., and Richardson D.R. The membrane-bound transferrin homologue melanotransferrin: roles other than iron transport?. FEBS Lett. 483 (2000) 11-16
14. Suryo Rahmanto Y., Dunn L.L., and Richardson D.R. The melanoma tumor antigen, melanotransferrin (p97): a 25-year hallmark - from iron metabolism to tumorigenesis. Oncogene 26 (2007) 6113-6124
15. Baker E.N., Baker H.M., Smith C.A., Stebbins M.R., Kahn M., Hellstrom K.E., and Hellstrom I. Human melanotransferrin (p97) has only one functional iron-binding site. FEBS Lett. 298 (1992) 215-218
16. Kennard M.L., Richardson D.R., Gabathuler R., Ponka P., and Jefferies W.A. A novel iron uptake mechanism mediated by GPI-anchored human p97. EMBO J. 14 (1995) 4178-4186
17. Food M.R., Rothenberger S., Gabathuler R., Haidl I.D., Reid G., and Jefferies W.A. Transport and expression in human melanomas of a transferrin-like glycosylphosphatidylinositol-anchored protein. J. Biol. Chem. 269 (1994) 3034-3040
18. Dunn L.L., Sekyere E.O., Rahmanto Y.S., and Richardson D.R. The function of melanotransferrin: a role in melanoma cell proliferation and tumorigenesis. Carcinogenesis 27 (2006) 2157-2169
19. Sekyere E.O., Dunn L.L., Rahmanto Y.S., and Richardson D.R. Role of melanotransferrin in iron metabolism: studies using targeted gene disruption in vivo. Blood 107 (2006) 2599-2601
20. Richardson D., and Baker E. The uptake of inorganic iron complexes by human melanoma cells. Biochim. Biophys. Acta 1093 (1991) 20-28
21. Richardson D.R. The role of the membrane-bound tumour antigen, melanotransferrin (p97), in iron uptake by the human malignant melanoma cell. Eur. J. Biochem. 267 (2000) 1290-1298
22. Richardson D.R., and Baker E. The release of iron and transferrin from the human melanoma cell. Biochim. Biophys. Acta 1091 (1991) 294-302
23. Food M.R., Sekyere E.O., and Richardson D.R. The soluble form of the membrane-bound transferrin homologue, melanotransferrin, inefficiently donates iron to cells via nonspecific internalization and degradation of the protein. Eur. J. Biochem. 269 (2002) 4435-4445
24. Demeule M., Poirier J., Jodoin J., Bertrand Y., Desrosiers R.R., Dagenais C., Nguyen T., Lanthier J., Gabathuler R., Kennard M., Jefferies W.A., Karkan D., Tsai S., Fenart L., Cecchelli R., and Beliveau R. High transcytosis of melanotransferrin (P97) across the blood-brain barrier. J. Neurochem. 83 (2002) 924-933
25. Moroo I., Ujiie M., Walker B.L., Tiong J.W., Vitalis T.Z., Karkan D., Gabathuler R., Moise A.R., and Jefferies W.A. Identification of a novel route of iron transcytosis across the mammalian blood-brain barrier. Microcirculation 10 (2003) 457-462
26. Jefferies W.A., Food M.R., Gabathuler R., Rothenberger S., Yamada T., Yasuhara O., and McGeer P.L. Reactive microglia specifically associated with amyloid plaques in Alzheimer's disease brain tissue express melanotransferrin. Brain Res. 712 (1996) 122-126
27. Desrosiers R.R., Bertrand Y., Nguyen Q.T., Demeule M., Gabathuler R., Kennard M.L., Gauthier S., and Beliveau R. Expression of melanotransferrin isoforms in human serum: relevance to Alzheimer's disease. Biochem. J. 374 (2003) 463-471
28. Suryo Rahmanto Y., Dunn L.L., and Richardson D.R. Identification of distinct changes in gene expression after modulation of melanoma tumor antigen p97 (Melanotransferrin) in multiple models in vitro and in vivo. Carcinogenesis 28 (2007) 2172-2183
29. Sala R., Jefferies W.A., Walker B., Yang J., Tiong J., Law S.K., Carlevaro M.F., Di Marco E., Vacca A., Cancedda R., Cancedda F.D., and Ribatti D. The human melanoma associated protein melanotransferrin promotes endothelial cell migration and angiogenesis in vivo. Eur. J. Cell Biol. 81 (2002) 599-607
30. Bertrand Y., Demeule M., Michaud-Levesque J., and Beliveau R. Melanotransferrin induces human melanoma SK-Mel-28 cell invasion in vivo. Biochem. Biophys. Res. Commun. 353 (2007) 418-423
31. Rolland Y., Demeule M., and Beliveau R. Melanotransferrin stimulates t-PA-dependent activation of plasminogen in endothelial cells leading to cell detachment. Biochim. Biophys. Acta 1763 (2006) 393-401
32. Frank N.Y., Pendse S.S., Lapchak P.H., Margaryan A., Shlain D., Doeing C., Sayegh M.H., and Frank M.H. Regulation of progenitor cell fusion by ABCB5 P-glycoprotein, a novel human ATP-binding cassette transporter. J. Biol. Chem. 278 (2003) 47156-47165
33. Graham T.A., Ferkey D.M., Mao F., Kimelman D., and Xu W. Tcf4 can specifically recognize beta-catenin using alternative conformations. Nat. Struct. Biol. 8 (2001) 1048-1052
34. Mann B., Gelos M., Siedow A., Hanski M.L., Gratchev A., Ilyas M., Bodmer W.F., Moyer M.P., Riecken E.O., Buhr H.J., and Hanski C. Target genes of beta-catenin-T cell-factor/lymphoid-enhancer-factor signaling in human colorectal carcinomas. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 1603-1608
35. Zhao D.H., Hong J.J., Guo S.Y., Yang R.L., Yuan J., Wen C.Y., Zhou K.Y., and Li C.J. Aberrant expression and function of TCF4 in the proliferation of hepatocellular carcinoma cell line BEL-7402. Cell Res. 14 (2004) 74-80
36. Makarchikov A.F., Lakaye B., Gulyai I.E., Czerniecki J., Coumans B., Wins P., Grisar T., and Bettendorff L. Thiamine triphosphate and thiamine triphosphatase activities: from bacteria to mammals. Cell. Mol. Life Sci. 60 (2003) 1477-1488
37. Lois C., Hong E.J., Pease S., Brown E.J., and Baltimore D. Germline transmission and tissue-specific expression of transgenes delivered by lentiviral vectors. Science 295 (2002) 868-872
38. Schorpp M., Jager R., Schellander K., Schenkel J., Wagner E.F., Weiher H., and Angel P. The human ubiquitin C promoter directs high ubiquitous expression of transgenes in mice. Nucleic Acids Res. 24 (1996) 1787-1788
39. Naldini L., Blomer U., Gallay P., Ory D., Mulligan R., Gage F.H., Verma I.M., and Trono D. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272 (1996) 263-267
40. Naldini L. Lentiviruses as gene transfer agents for delivery to non-dividing cells. Curr. Opin. Biotechnol. 9 (1998) 457-463
41. Zufferey R., Donello J.E., Trono D., and Hope T.J. Woodchuck hepatitis virus posttranscriptional regulatory element enhances expression of transgenes delivered by retroviral vectors. J. Virol. 73 (1999) 2886-2892
42. Ngoi S.M., Chien A.C., and Lee C.G. Exploiting internal ribosome entry sites in gene therapy vector design. Curr. Gene Ther. 4 (2004) 15-31
43. Sekyere E.O., Dunn L.L., and Richardson D.R. Examination of the distribution of the transferrin homologue, melanotransferrin (tumour antigen p97), in mouse and human. Biochim. Biophys. Acta 1722 (2005) 131-142
44. Gao J., and Richardson D.R. The potential of iron chelators of the pyridoxal isonicotinoyl hydrazone class as effective antiproliferative agents, IV: the mechanisms involved in inhibiting cell-cycle progression. Blood 98 (2001) 842-850
45. In: Kingston H., and Jassie L. (Eds). Introduction to Microwave Sample Preparation. Theory and Practice (1988), American Chemical Society, Washington, DC
46. Kennard M.L., Feldman H., Yamada T., and Jefferies W.A. Serum levels of the iron binding protein p97 are elevated in Alzheimer's disease. Nat. Med. 2 (1996) 1230-1235
47. Dunn L.L., Rahmanto Y.S., and Richardson D.R. Iron uptake and metabolism in the new millennium. Trends Cell Biol. 17 (2007) 93-100
48. Taconic, Technical library: Taconic B6 phenotyping, vol. 2005.
49. Sproule T.J., Jazwinska E.C., Britton R.S., Bacon B.R., Fleming R.E., Sly W.S., and Roopenian D.C. Naturally variant autosomal and sex-linked loci determine the severity of iron overload in beta 2-microglobulin-deficient mice. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 5170-5174
50. Morgan E.H. Transferrin: biochemistry, physiology and clinical significance. Mol. Aspects Med. 4 (1981) 1-123
51. Karolchik D., Baertsch R., Diekhans M., Furey T.S., Hinrichs A., Lu Y.T., Roskin K.M., Schwartz M., Sugnet C.W., Thomas D.J., Weber R.J., Haussler D., and Kent W.J. The UCSC genome browser database. Nucleic Acids Res. 31 (2003) 51-54